BinaxNOW COVID-19 AG Rapid is a rapid antigen diagnostic test designed for the qualitative detection of SARS-CoV-2 nucleocapsid protein in nasal swab specimens. Delivering results in approximately 15 minutes, this point-of-care test supports timely clinical decision-making in skilled nursing facilities, home health programs, and long-term care settings where rapid identification of COVID-19 is critical for infection control and patient safety. Authorized for use with or without a prescription depending on applicable guidelines, BinaxNOW enables healthcare teams to quickly screen symptomatic and asymptomatic individuals, facilitating prompt isolation protocols and helping minimize the risk of facility-wide outbreak events.